HomeNewsResearch Paper – Real-life validation of the PanbioTM COVID-19 antigen rapid test (Abbott) in community-dwelling subjects with symptoms of potential SARS-CoV-2 infection
22Apr
Research Paper – Real-life validation of the PanbioTM COVID-19 antigen rapid test (Abbott) in community-dwelling subjects with symptoms of potential SARS-CoV-2 infection
During the Covid-19 pandemic there was an increasing demand for easy, reliable, and fast SARS-CoV-2 antigen testing for out of laboratory use. LABHOH promptly responded to this demand in Aruba and collaborated with the University Medical Centre Utrecht (UMCU) to validate the diagnostic performance of the PanbioTM COVID-19 Ag Rapid Test (Abbott). Persons with mild complaints as well as patients submitted to a hospital for Covid-19 treatment (critically ill patients were excluded) were included in this study. RT-qPCR (Seegene Allplex) was used as the reference test for identification of active SARS-CoV-2 infection. The results of this study is reported in this peer-reviewed publication. User friendly and low cost SARS-CoV-2 antigen tests with short turn-around times were widely used in Aruba to improve efforts aimed at controling transmission of the virus during the pandemic.
